Cencora Logo

Cencora

COR

(1.5)
Stock Price

235,64 USD

3.49% ROA

199.06% ROE

23.58x PER

Market Cap.

43.509.948.070,00 USD

511.35% DER

0.92% Yield

0.65% NPM

Cencora Stock Analysis

Cencora Fundamental Analysis

Fundamental analysis in stock investing is like studying the foundation of a house before buying it. It involves looking at a company's financial health, like its earnings, assets, and debts, to determine if it's a good investment based on its fundamental strength and potential for growth.

Cencora Fundamental Stock Analysis
# Analysis Rating
1 ROE

The stock's ROE exceeds expectations (555.31%), revealing strong profitability and efficient use of shareholders' equity, making it an attractive investment opportunity.

2 Revenue Growth

Over the past five years, this company's revenue has consistently increased, demonstrating a robust financial performance that makes it an appealing opportunity.

3 ROA

The stock's ROA (3.61%) shows that it's doing a pretty good job at making money from its assets, making it a solid choice to invest and earn steady profits.

4 Net Profit Growth

Throughout the last three years, this company has experienced consistent net profit growth, reflecting a robust financial performance and making it an attractive investment prospect.

5 PBV

The stock's high Price-to-Book Value (P/BV) ratio (43.16x) suggests it's overvalued, potentially making it an expensive investment.

6 DER

The stock is burdened with a heavy load of debt (545%), making it financially unstable and potentially risky for investors.

7 Assets Growth

Company's revenue has remained stagnant over the past three years, indicating a lack of growth and making it a less favorable option.

8 Graham Number

The Graham number analysis indicates that this company's stock price is likely overpriced, raising concerns about its investment potential.

9 Dividend Growth

The company's dividend growth has remained unchanged for three years, signaling a lack of positive momentum and making it a less favorable investment choice.

10 Dividend

The company's lack of dividends in the past three years may concern investors seeking regular income.

11 Buffet Intrinsic Value

Based on Warren Buffett's formula, the company's stock seems overpriced (-284.402), indicating a potential drawback for investors as its market price exceeds its estimated intrinsic value.

Cencora Technical Analysis

Technical analysis in stock investing is like reading the patterns on a weather map to predict future weather conditions. It involves studying past stock price movements and trading volumes to make predictions about where a stock's price might go next, without necessarily looking at the company's financial health.

Cencora Technical Stock Analysis
# Analysis Recommendation
1 Awesome Oscillator Sell
2 MACD Buy
3 RSI Hold
4 Stoch RSI Sell

Cencora Price Chart

Financial Statements

Financial statements are like report cards for companies. They show how much money a company makes (income statement), what it owns and owes (balance sheet), and where it spends its money (cash flow statement), helping stock investors understand if a company is healthy and worth investing in.

Income Statements

An income statement for a company is like a scoreboard for its profits and losses. It shows how much money the company made (revenue) and how much it spent to make that money (expenses), helping stock investors see if a company is making a profit or not.

Revenue in stock investing is the total amount of money a company earns from its sales, and it's a key factor that investors consider to assess a company's financial performance and growth potential.

Cencora Revenue
Year Revenue Growth
1994 4.301.800.000
1995 4.668.900.000 7.86%
1996 5.551.700.000 15.9%
1997 7.815.900.000 28.97%
1998 8.668.800.000 9.84%
1999 9.807.400.000 11.61%
2000 11.645.021.000 15.78%
2001 16.191.353.000 28.08%
2002 45.234.794.000 64.21%
2003 49.657.328.000 8.91%
2004 53.178.954.000 6.62%
2005 54.577.321.000 2.56%
2006 61.203.145.000 10.83%
2007 66.074.312.000 7.37%
2008 15.581.000 -423969.78%
2008 70.189.733.000 99.98%
2009 28.831.000 -243352.3%
2009 71.759.990.000 99.96%
2010 73.909.000 -96992.36%
2010 77.953.979.000 99.91%
2011 172.846.000 -45000.25%
2011 80.217.558.000 99.78%
2012 78.080.806.000 -2.74%
2012 78.080.806.000 0%
2013 87.959.167.000 11.23%
2013 87.959.167.000 0%
2014 119.569.127.000 26.44%
2014 119.569.127.000 0%
2015 135.961.803.000 12.06%
2015 135.961.803.000 0%
2016 146.849.686.000 7.41%
2016 146.849.686.000 0%
2017 153.143.826.000 4.11%
2017 153.143.826.000 0%
2018 167.939.635.000 8.81%
2018 167.939.635.000 0%
2019 179.589.121.000 6.49%
2020 189.893.926.000 5.43%
2021 213.988.843.000 11.26%
2022 238.587.006.000 10.31%
2023 262.173.411.000 9%
2024 296.965.412.000 11.72%

Research and Development Expenses are the costs a company incurs to create and improve its products or services, which can be important for investors to evaluate a company's innovation and potential for future growth.

Cencora Research and Development Expenses
Year Research and Development Expenses Growth
1994 0
1995 0 0%
1996 0 0%
1997 0 0%
1998 0 0%
1999 0 0%
2000 0 0%
2001 0 0%
2002 0 0%
2003 0 0%
2004 0 0%
2005 0 0%
2006 0 0%
2007 0 0%
2008 0 0%
2008 0 0%
2009 0 0%
2009 0 0%
2010 0 0%
2010 0 0%
2011 0 0%
2011 0 0%
2012 0 0%
2012 0 0%
2013 0 0%
2013 0 0%
2014 0 0%
2014 0 0%
2015 0 0%
2015 0 0%
2016 0 0%
2016 0 0%
2017 0 0%
2017 0 0%
2018 0 0%
2018 0 0%
2019 0 0%
2020 0 0%
2021 0 0%
2022 0 0%
2023 0 0%
2024 0 0%

General and Administrative Expenses are the costs a company incurs to run its day-to-day operations, such as office rent, salaries, and utilities, which investors consider to understand a company's overall efficiency and management effectiveness.

Cencora General and Administrative Expenses
Year General and Administrative Expenses Growth
1994 150.700.000
1995 160.900.000 6.34%
1996 195.400.000 17.66%
1997 255.400.000 23.49%
1998 254.900.000 -0.2%
1999 281.800.000 9.55%
2000 303.038.000 7.01%
2001 408.760.000 25.86%
2002 1.220.651.000 66.51%
2003 1.293.062.000 5.6%
2004 1.212.982.000 -6.6%
2005 1.256.780.000 3.48%
2006 1.397.100.000 10.04%
2007 1.413.103.000 1.13%
2008 5.472.000 -25724.25%
2008 5.472.000 0%
2009 6.461.000 15.31%
2009 6.461.000 0%
2010 20.830.000 68.98%
2010 20.830.000 0%
2011 41.057.000 49.27%
2011 41.057.000 0%
2012 44.621.000 7.99%
2012 44.621.000 0%
2013 46.976.000 5.01%
2013 46.976.000 0%
2014 48.239.000 2.62%
2014 48.239.000 0%
2015 55.254.000 12.7%
2015 55.254.000 0%
2016 58.000.000 4.73%
2016 58.000.000 0%
2017 61.673.000 5.96%
2017 61.673.000 0%
2018 67.786.000 9.02%
2018 67.786.000 0%
2019 76.388.000 11.26%
2020 80.573.000 5.19%
2021 0 0%
2022 0 0%
2023 0 0%
2024 0 0%

EBITDA stands for Earnings Before Interest, Taxes, Depreciation, and Amortization. It is a measure that helps stock investors analyze a company's profitability by looking at its earnings without considering certain expenses. This helps to get a clearer picture of the company's financial performance and its ability to generate cash flow.

Cencora EBITDA
Year EBITDA Growth
1994 272.400.000
1995 107.900.000 -152.46%
1996 109.500.000 1.46%
1997 133.900.000 18.22%
1998 194.900.000 31.3%
1999 208.700.000 6.61%
2000 216.731.000 3.71%
2001 307.592.000 29.54%
2002 833.494.000 63.1%
2003 967.769.000 13.87%
2004 994.878.000 2.72%
2005 843.985.000 -17.88%
2006 841.252.000 -0.32%
2007 931.834.000 9.72%
2008 -4.074.000 22972.7%
2008 950.524.000 100.43%
2009 5.956.000 -15859.1%
2009 974.429.000 99.39%
2010 29.780.000 -3172.09%
2010 1.193.296.000 97.5%
2011 67.451.000 -1669.13%
2011 1.319.449.000 94.89%
2012 75.715.000 -1642.65%
2012 75.715.000 0%
2013 85.977.000 11.94%
2013 85.977.000 0%
2014 106.939.000 19.6%
2014 106.939.000 0%
2015 136.429.000 21.62%
2015 136.429.000 0%
2016 178.759.000 23.68%
2016 178.759.000 0%
2017 226.751.000 21.17%
2017 226.751.000 0%
2018 252.701.000 10.27%
2018 252.701.000 0%
2019 2.487.756.000 89.84%
2020 2.426.248.000 -2.54%
2021 3.408.797.000 28.82%
2022 3.474.757.000 1.9%
2023 3.698.545.000 6.05%
2024 3.929.212.000 5.87%

Gross profit is the money a company makes from selling its products or services after subtracting the cost of producing or providing them, and it is an important measure for investors to understand a company's profitability.

Cencora Gross Profit
Year Gross Profit Growth
1994 243.300.000
1995 268.800.000 9.49%
1996 304.900.000 11.84%
1997 389.300.000 21.68%
1998 423.100.000 7.99%
1999 475.600.000 11.04%
2000 520.892.000 8.7%
2001 700.118.000 25.6%
2002 2.024.474.000 65.42%
2003 2.247.159.000 9.91%
2004 2.179.182.000 -3.12%
2005 1.980.184.000 -10.05%
2006 2.231.815.000 11.27%
2007 2.326.739.000 4.08%
2008 4.323.000 -53722.32%
2008 2.047.002.000 99.79%
2009 14.877.000 -13659.51%
2009 2.100.075.000 99.29%
2010 47.530.000 -4318.42%
2010 2.356.642.000 97.98%
2011 117.797.000 -1900.6%
2011 2.539.096.000 95.36%
2012 2.619.873.000 3.08%
2012 2.619.873.000 0%
2013 2.484.936.000 -5.43%
2013 2.484.936.000 0%
2014 2.957.930.000 15.99%
2014 2.957.930.000 0%
2015 3.463.820.000 14.6%
2015 3.463.820.000 0%
2016 4.138.848.000 16.31%
2016 4.138.848.000 0%
2017 4.544.607.000 8.93%
2017 4.544.607.000 0%
2018 4.576.379.000 0.69%
2018 4.576.379.000 0%
2019 5.138.312.000 10.94%
2020 5.195.364.000 1.1%
2021 6.774.434.000 23.31%
2022 8.334.565.000 18.72%
2023 8.959.493.000 6.98%
2024 8.346.308.000 -7.35%

Net income in stock investing is like the money a company actually gets to keep as profit after paying all its bills, and it's an important measure to understand how well a company is doing financially.

Cencora Net Profit
Year Net Profit Growth
1994 -207.700.000
1995 10.200.000 2136.27%
1996 35.500.000 71.27%
1997 45.400.000 21.81%
1998 50.500.000 10.1%
1999 67.500.000 25.19%
2000 99.014.000 31.83%
2001 125.102.000 20.85%
2002 344.941.000 63.73%
2003 441.229.000 21.82%
2004 468.390.000 5.8%
2005 319.199.000 -46.74%
2006 467.714.000 31.75%
2007 469.167.000 0.31%
2008 -13.888.000 3478.22%
2008 250.559.000 105.54%
2009 -7.039.000 3659.58%
2009 503.397.000 101.4%
2010 -4.906.000 10360.84%
2010 636.748.000 100.77%
2011 -4.611.000 13909.33%
2011 706.624.000 100.65%
2012 5.048.000 -13898.1%
2012 5.048.000 0%
2013 18.841.000 73.21%
2013 18.841.000 0%
2014 22.765.000 17.24%
2014 22.765.000 0%
2015 34.706.000 34.41%
2015 34.706.000 0%
2016 58.709.000 40.88%
2016 58.709.000 0%
2017 74.855.000 21.57%
2017 74.855.000 0%
2018 77.922.000 3.94%
2018 77.922.000 0%
2019 855.365.000 90.89%
2020 -3.408.716.000 125.09%
2021 1.539.932.000 321.35%
2022 1.698.820.000 9.35%
2023 1.745.293.000 2.66%
2024 1.933.852.000 9.75%

EPS, or earnings per share, is a measure that shows how much profit a company has earned for each outstanding share of its stock, and it is important for stock investors as it helps understand the profitability of a company and compare it with other companies in the market.

Cencora Earning per Share (EPS)
Year Earning per Share (EPS) Growth
1994 -5
1995 0 0%
1996 0 0%
1997 0 0%
1998 0 0%
1999 0 0%
2000 0 0%
2001 1 0%
2002 1 0%
2003 1 0%
2004 1 100%
2005 1 0%
2006 1 100%
2007 1 0%
2008 -1 0%
2008 1 0%
2009 0 0%
2009 2 100%
2010 0 0%
2010 2 100%
2011 0 0%
2011 3 100%
2012 0 0%
2012 0 0%
2013 1 0%
2013 0 0%
2014 1 100%
2014 0 0%
2015 1 100%
2015 0 0%
2016 2 100%
2016 0 0%
2017 2 100%
2017 0 0%
2018 2 100%
2018 0 0%
2019 4 100%
2020 -17 125%
2021 7 328.57%
2022 8 12.5%
2023 9 0%
2024 10 11.11%

Cashflow Statements

Cashflow statements show the movement of money in and out of a company, helping stock investors understand how much money a company makes and spends. By examining cashflow statements, investors can assess if a company is generating enough cash to pay its bills, invest in growth, and provide returns to stockholders.

Free cash flow is the leftover cash that a company generates after covering its operating expenses and capital expenditures, which is important for stock investors as it shows how much money a company has available to invest in growth, pay dividends, or reduce debt.

Cencora Free Cashflow
Year Free Cashflow Growth
1994 75.500.000
1995 -49.300.000 253.14%
1996 24.300.000 302.88%
1997 -25.200.000 196.43%
1998 115.500.000 121.82%
1999 -12.800.000 1002.34%
2000 199.961.000 106.4%
2001 -63.367.000 415.56%
2002 471.767.000 113.43%
2003 264.261.000 -78.52%
2004 635.803.000 58.44%
2005 1.323.262.000 51.95%
2006 694.133.000 -90.64%
2007 1.089.853.000 36.31%
2008 599.760.000 -81.71%
2008 599.760.000 0%
2009 637.926.000 5.98%
2009 637.926.000 0%
2010 923.989.000 30.96%
2010 923.989.000 0%
2011 999.994.000 7.6%
2011 999.994.000 0%
2012 1.141.408.000 12.39%
2012 1.141.408.000 0%
2013 585.675.000 -94.89%
2013 585.675.000 0%
2014 1.198.696.000 51.14%
2014 1.198.696.000 0%
2015 3.688.794.000 67.5%
2015 3.688.794.000 0%
2016 2.713.881.000 -35.92%
2016 2.713.881.000 0%
2017 1.022.610.000 -165.39%
2017 1.022.610.000 0%
2018 1.074.977.000 4.87%
2018 1.074.977.000 0%
2019 2.033.801.000 47.14%
2020 1.837.363.000 -10.69%
2021 2.228.369.000 17.55%
2022 2.206.770.000 -0.98%
2023 3.452.975.000 36.09%
2024 2.359.713.000 -46.33%

Operating cash flow represents the cash generated or consumed by a company's day-to-day operations, excluding external investing or financing activities, and is crucial for stock investors as it shows how much cash a company is generating from its core business operations.

Cencora Operating Cashflow
Year Operating Cashflow Growth
1994 84.000.000
1995 -35.600.000 335.96%
1996 40.000.000 189%
1997 -9.300.000 530.11%
1998 125.900.000 107.39%
1999 3.000.000 -4096.67%
2000 216.580.000 98.61%
2001 -40.004.000 641.4%
2002 535.926.000 107.46%
2003 354.815.000 -51.04%
2004 825.081.000 57%
2005 1.526.638.000 45.95%
2006 807.265.000 -89.11%
2007 1.207.904.000 33.17%
2008 737.069.000 -63.88%
2008 737.069.000 0%
2009 783.763.000 5.96%
2009 783.763.000 0%
2010 1.108.624.000 29.3%
2010 1.108.624.000 0%
2011 1.167.948.000 5.08%
2011 1.167.948.000 0%
2012 1.305.449.000 10.53%
2012 1.305.449.000 0%
2013 788.125.000 -65.64%
2013 788.125.000 0%
2014 1.463.153.000 46.14%
2014 1.463.153.000 0%
2015 3.920.379.000 62.68%
2015 3.920.379.000 0%
2016 3.178.497.000 -23.34%
2016 3.178.497.000 0%
2017 1.489.007.000 -113.46%
2017 1.489.007.000 0%
2018 1.411.388.000 -5.5%
2018 1.411.388.000 0%
2019 2.344.023.000 39.79%
2020 2.207.040.000 -6.21%
2021 2.666.586.000 17.23%
2022 2.703.088.000 1.35%
2023 3.911.334.000 30.89%
2024 2.477.592.000 -57.87%

Capex, short for capital expenditures, refers to the money a company spends on acquiring or upgrading tangible assets like buildings, equipment, or technology, which is important for stock investors as it indicates how much a company is investing in its infrastructure to support future growth and profitability.

Cencora Capital Expenditure
Year Capital Expenditure Growth
1994 8.500.000
1995 13.700.000 37.96%
1996 15.700.000 12.74%
1997 15.900.000 1.26%
1998 10.400.000 -52.88%
1999 15.800.000 34.18%
2000 16.619.000 4.93%
2001 23.363.000 28.87%
2002 64.159.000 63.59%
2003 90.554.000 29.15%
2004 189.278.000 52.16%
2005 203.376.000 6.93%
2006 113.132.000 -79.77%
2007 118.051.000 4.17%
2008 137.309.000 14.03%
2008 137.309.000 0%
2009 145.837.000 5.85%
2009 145.837.000 0%
2010 184.635.000 21.01%
2010 184.635.000 0%
2011 167.954.000 -9.93%
2011 167.954.000 0%
2012 164.041.000 -2.39%
2012 164.041.000 0%
2013 202.450.000 18.97%
2013 202.450.000 0%
2014 264.457.000 23.45%
2014 264.457.000 0%
2015 231.585.000 -14.19%
2015 231.585.000 0%
2016 464.616.000 50.16%
2016 464.616.000 0%
2017 466.397.000 0.38%
2017 466.397.000 0%
2018 336.411.000 -38.64%
2018 336.411.000 0%
2019 310.222.000 -8.44%
2020 369.677.000 16.08%
2021 438.217.000 15.64%
2022 496.318.000 11.71%
2023 458.359.000 -8.28%
2024 117.879.000 -288.84%

Balance Sheet

Balance sheets provide a snapshot of a company's financial health and its assets (such as cash, inventory, and property) and liabilities (like debts and obligations) at a specific point in time. For stock investors, balance sheets help assess the company's overall worth and evaluate its ability to meet financial obligations and support future growth.

Equity refers to the ownership interest or stake that shareholders have in a company, representing their claim on its assets and earnings after all debts and liabilities are paid.

Cencora Equity
Year Equity Growth
1994 -300.700.000
1995 -135.700.000 -121.59%
1996 -36.800.000 -268.75%
1997 14.300.000 357.34%
1998 75.300.000 81.01%
1999 166.300.000 54.72%
2000 282.294.000 41.09%
2001 2.838.564.000 90.06%
2002 3.316.338.000 14.41%
2003 4.005.317.000 17.2%
2004 4.339.045.000 7.69%
2005 4.280.357.000 -1.37%
2006 4.141.157.000 -3.36%
2007 3.099.720.000 -33.6%
2008 2.710.045.000 -14.38%
2008 149.103.000 -1717.57%
2009 2.716.469.000 94.51%
2009 162.338.000 -1573.34%
2010 2.954.297.000 94.51%
2010 232.239.000 -1172.09%
2011 2.868.965.000 91.91%
2011 232.808.000 -1132.33%
2012 2.456.712.000 90.52%
2012 338.229.000 -626.35%
2013 2.319.745.000 85.42%
2013 332.410.000 -597.86%
2014 1.956.899.000 83.01%
2014 322.587.000 -506.63%
2015 633.520.000 49.08%
2015 416.117.000 -52.25%
2016 2.129.404.000 80.46%
2016 435.726.000 -388.7%
2017 2.064.460.999 78.89%
2017 281.020.000 -634.63%
2018 3.049.961.000 90.79%
2018 242.555.000 -1157.43%
2019 3.107.495.000 92.19%
2020 -660.348.000 570.58%
2021 584.411.000 212.99%
2022 -6.952.000 8506.37%
2023 810.571.000 100.86%
2024 1.060.503.000 23.57%

Assets represent the valuable resources that a company owns, such as cash, inventory, property, and equipment, and understanding a company's assets helps investors assess its value and potential for generating future profits.

Cencora Assets
Year Assets Growth
1994 711.600.000
1995 838.700.000 15.15%
1996 1.188.000.000 29.4%
1997 1.745.000.000 31.92%
1998 1.552.300.000 -12.41%
1999 2.060.600.000 24.67%
2000 2.458.567.000 16.19%
2001 10.291.245.000 76.11%
2002 11.213.012.000 8.22%
2003 12.040.125.000 6.87%
2004 11.654.003.000 -3.31%
2005 11.381.174.000 -2.4%
2006 12.783.920.000 10.97%
2007 12.310.064.000 -3.85%
2008 12.217.786.000 -0.76%
2008 213.846.000 -5613.36%
2009 13.572.740.000 98.42%
2009 239.420.000 -5569.01%
2010 14.434.843.000 98.34%
2010 833.026.000 -1632.82%
2011 14.982.671.000 94.44%
2011 808.226.000 -1753.77%
2012 15.444.126.000 94.77%
2012 845.332.000 -1726.99%
2013 18.918.638.000 95.53%
2013 1.016.494.000 -1761.17%
2014 21.532.183.000 95.28%
2014 1.075.425.000 -1902.2%
2015 27.736.157.000 96.12%
2015 1.162.543.000 -2285.82%
2016 33.637.500.999 96.54%
2016 1.451.303.000 -2217.74%
2017 35.316.470.000 95.89%
2017 1.532.659.000 -2204.26%
2018 38.018.140.000 95.97%
2018 1.853.667.000 -1950.97%
2019 39.171.980.000 95.27%
2020 43.947.863.000 10.87%
2021 57.337.805.000 23.35%
2022 56.560.616.000 -1.37%
2023 62.558.746.000 9.59%
2024 66.772.422.999 6.31%

Liabilities refer to the financial obligations or debts that a company owes to creditors or external parties, and understanding a company's liabilities is important for investors as it helps assess the company's financial risk and ability to meet its obligations.

Cencora Liabilities
Year Liabilities Growth
1994 1.012.300.000
1995 974.400.000 -3.89%
1996 1.224.800.000 20.44%
1997 1.730.700.000 29.23%
1998 1.477.000.000 -17.18%
1999 1.894.300.000 22.03%
2000 2.176.273.000 12.96%
2001 7.452.681.000 70.8%
2002 7.896.674.000 5.62%
2003 8.034.808.000 1.72%
2004 7.314.958.000 -9.84%
2005 7.100.817.000 -3.02%
2006 8.642.763.000 17.84%
2007 9.210.344.000 6.16%
2008 9.507.741.000 3.13%
2008 64.743.000 -14585.36%
2009 10.856.271.000 99.4%
2009 77.082.000 -13984.05%
2010 11.480.546.000 99.33%
2010 178.561.000 -6329.48%
2011 12.113.706.000 98.53%
2011 188.039.000 -6342.12%
2012 12.987.414.000 98.55%
2012 134.559.000 -9551.84%
2013 16.598.893.000 99.19%
2013 328.187.000 -4957.75%
2014 19.575.284.000 98.32%
2014 417.084.000 -4593.37%
2015 27.102.637.000 98.46%
2015 536.238.000 -4954.22%
2016 31.508.097.000 98.3%
2016 854.217.000 -3588.54%
2017 33.252.009.000 97.43%
2017 1.114.015.000 -2884.88%
2018 34.968.179.000 96.81%
2018 1.519.034.000 -2202%
2019 36.178.774.000 95.8%
2020 44.787.499.000 19.22%
2021 56.753.394.000 21.08%
2022 56.489.343.000 -0.47%
2023 61.892.459.000 8.73%
2024 65.711.920.000 5.81%

Cencora Financial Ratio (TTM)

Valuation Metrics

Revenue per Share
1431.61
Net Income per Share
9.36
Price to Earning Ratio
23.58x
Price To Sales Ratio
0.15x
POCF Ratio
10.15
PFCF Ratio
11.36
Price to Book Ratio
47.32
EV to Sales
0.16
EV Over EBITDA
11.07
EV to Operating CashFlow
10.4
EV to FreeCashFlow
11.7
Earnings Yield
0.04
FreeCashFlow Yield
0.09
Market Cap
43,51 Bil.
Enterprise Value
44,83 Bil.
Graham Number
31.35
Graham NetNet
-176.93

Income Statement Metrics

Net Income per Share
9.36
Income Quality
2.32
ROE
1.99
Return On Assets
0.03
Return On Capital Employed
0.2
Net Income per EBT
0.8
EBT Per Ebit
0.83
Ebit per Revenue
0.01
Effective Tax Rate
0.2

Margins

Sales, General, & Administrative to Revenue
0
Research & Developement to Revenue
0
Stock Based Compensation to Revenue
0
Gross Profit Margin
0.03
Operating Profit Margin
0.01
Pretax Profit Margin
0.01
Net Profit Margin
0.01

Dividends

Dividend Yield
0.01
Dividend Yield %
0.92
Payout Ratio
0.22
Dividend Per Share
2.04

Operating Metrics

Operating Cashflow per Share
21.74
Free CashFlow per Share
19.32
Capex to Operating CashFlow
0.11
Capex to Revenue
0
Capex to Depreciation
0.44
Return on Invested Capital
0.4
Return on Tangible Assets
0.03
Days Sales Outstanding
30.99
Days Payables Outstanding
66.19
Days of Inventory on Hand
24.28
Receivables Turnover
11.78
Payables Turnover
5.51
Inventory Turnover
15.03
Capex per Share
2.42

Balance Sheet

Cash per Share
17,20
Book Value per Share
5,35
Tangible Book Value per Share
-63.37
Shareholders Equity per Share
4.67
Interest Debt per Share
25.15
Debt to Equity
5.11
Debt to Assets
0.07
Net Debt to EBITDA
0.33
Current Ratio
0.89
Tangible Asset Value
-12,56 Bil.
Net Current Asset Value
-18,40 Bil.
Invested Capital
10038837000
Working Capital
-5,67 Bil.
Intangibles to Total Assets
0.2
Average Receivables
23,37 Bil.
Average Payables
48,10 Bil.
Average Inventory
18563723000
Debt to Market Cap
0.11

Dividends

Dividends in stock investing are like rewards that companies give to their shareholders. They are a portion of the company's profits distributed to investors, typically in the form of cash payments, as a way for them to share in the company's success.

Cencora Dividends
Year Dividends Growth
2001 0
2002 1 100%
2003 1 0%
2004 1 0%
2005 1 0%
2006 1 0%
2007 16 93.75%
2008 3 -433.33%
2009 3 0%
2010 4 0%
2011 5 25%
2012 6 33.33%
2013 9 25%
2014 5 -60%
2015 1 -400%
2016 1 0%
2017 1 0%
2018 2 0%
2019 2 0%
2020 2 0%
2021 2 0%
2022 2 0%
2023 2 0%
2024 2 0%

Cencora Profile

About Cencora

Cencora, Inc. sources and distributes pharmaceutical products. Its U.S. Healthcare Solutions segment distributes pharmaceuticals, over-the-counter healthcare products, home healthcare supplies and equipment, and related services to acute care hospitals and health systems, independent and chain retail pharmacies, mail order pharmacies, medical clinics, long-term care and alternate site pharmacies, and other customers. The company also provides pharmacy management, staffing, and other consulting services; supply management software to retail and institutional healthcare providers; packaging solutions to various institutional and retail healthcare providers; clinical trial support, product post-approval, and commercialization support services; data analytics, outcomes research, and additional services for biotechnology and pharmaceutical manufacturers; and pharmaceuticals, vaccines, parasiticides, diagnostics, micro feed ingredients, and other products to the companion animal and production animal markets. In addition, this segment distributes plasma and other blood products, injectable pharmaceuticals, vaccines, and other specialty products; and provides other services primarily to physicians who specialize in various disease states, primarily oncology, as well as to other healthcare providers, including hospitals and dialysis clinics. The company's International Healthcare Solutions segment offers international pharmaceutical wholesale and related service, and global commercialization services; and distributes pharmaceuticals, other healthcare products, and related services to pharmacies, doctors, health centers and hospitals primarily in Europe. This segment also provides specialty transportation and logistics services for the biopharmaceutical industry. The company was formerly known as AmerisourceBergen Corporation and changed its name to Cencora, Inc. in August 2023. Cencora, Inc. was incorporated in 2001 and is headquartered in Conshohocken, Pennsylvania.

CEO
Dr. Robert P. Mauch Ph.D., Pha
Employee
46.000
Address
1 West First Avenue
Conshohocken, 19428

Cencora Executives & BODs

Cencora Executives & BODs
# Name Age
1 Bennett S. Murphy
Senior Vice President of Investor Relations
70
2 Mr. Steven H. Collis
Executive Chairman
70
3 Ms. Silvana Battaglia
Executive Vice President & Chief Human Resources Officer
70
4 Mr. J. F. Quinn
Vice President & Corporate Treasurer
70
5 Mr. Lazarus Krikorian
Senior Vice President, Chief Accounting Officer & Corporate Controller
70
6 Ms. Ann Anaya
Senior Vice President and Chief Diversity Equity & Inclusion Officer
70
7 Ms. Jennifer E. Dubas
Senior Vice President & Chief Compliance Officer
70
8 Ms. Elizabeth S. Campbell
Executive Vice President & Chief Legal Officer
70
9 Mr. James F. Cleary Jr.
Executive Vice President & Chief Financial Officer
70

Cencora Competitors